J Korean Orthop Assoc.  2003 Oct;38(6):568-572.

Total Hip Arthroplasty with Hydroxyapatite-coated ABG(R) Hip Prosthesis: Minimum 5 Year Follow-up

Affiliations
  • 1Department of Orthopedic Surgery, Kwangju Christian Hospital, Gwangju, Korea. paedic@chollian.net

Abstract

PURPOSE
To evaluate the clinical and radiological results of total hip arthroplasty (THA) with a hydroxyapatite (HA)-coated ABG(R) (AnatomicalBenoist Giraud, Howmedica, Europe) hip prosthesis. MATERIALS AND METHODS: From March 1992 to December 1996, we performed 204 total hip arthroplasty with HA-coated hip prosthesis. This study included 142 hips. The causes of THA were osteonecrosis of the femoral head (122 hips), osteoarthritis (16 hips) and infectionsequalae (4 hips). Clinical results were evaluated using Harris hip score. We observed osteointegration, cortical hypertrophy, reactiveline around femoral stem, subsidence, polyethylene wear, osteolysis and radiolucent line around acetabular cup on the follow-up radiographs. RESULTS: Harris hip score was an average of 84.5 points at last follow-up. Only one femoral stem was revised for loosening. Reactive lines around uncoated portion of femoral stem was observed in 70 hips. The cortical hypertrophy was observed at zone 2, 3, 5 and 6 in 46hips. Forty-five acetabular cups (31.7%) were revised. The causes of cup revision were polyethylene liner wear and osteolysis (24 hips), loosening (19 hips) and recurrent dislocation (2 hips). CONCLUSION: We found that the HA-coated ABG(R) femoral stem had high survival rate at minimum 5 years follow-up after THA, but acetabularcup had high revision rate for loosening and osteolysis.

Keyword

Total hip arthroplasty; HA-coated hip prosthesis

MeSH Terms

Acetabulum
Arthroplasty, Replacement, Hip*
Dislocations
Durapatite
Follow-Up Studies*
Head
Hip Prosthesis*
Hip*
Hypertrophy
Osteoarthritis
Osteolysis
Osteonecrosis
Polyethylene
Survival Rate
Durapatite
Polyethylene
Full Text Links
  • JKOA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr